Nancy Lynn Snyderman M.D. is Director at Alkermes plc. (ALKS). They have made 4 open-market trades across 3 companies since 2019, most recently 2026-08-03.
CIK 0001675198
3 open-market purchases totalling $94K since 2019, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AXNX | 14,944 | $1.1M |
| ALKS | 15,395 | $635K |
| LYRA | 1,025 | $507 |
| FHLT | 11,250 | — |
| Total | $1.7M |
Shares reported on the most recent Form 4, priced at the 2026-08-03 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.